Quick View
Loading...
Dragon Pharma
Estimated Delivery: 12-26 Days (International), 3-6 Days (United States)
Return within 45 Days of purchase. Duties & taxes are non-refundable.
Buy SLU-PP-332 1000 mcg tablets by Dragon Pharma at XSteroids. SLU-PP-332 is the ERR agonist that the research world calls an exercise mimetic - a compound that reproduced several metabolic effects of training in mice. Dragon Pharma supplies it as 1000 mcg tablets, 100 per pack. This guide covers what the receptor system does, what the mouse studies actually found, slu-pp-332 dosage questions and why the human data is missing.
SLU-PP-332 has no approved use and no human trials, so the information below is educational only.
SLU-PP-332 is an agonist of the estrogen-related receptors - ERR-alpha, ERR-beta and ERR-gamma. It is a pan-agonist across that family, and it has nothing to do with the androgen receptor: it is not a SARM and not a steroid, despite being sold in the same category as both.
The ERRs are constitutively active orphan nuclear receptors, meaning they do not wait for a hormone to switch on. They are expressed at high levels in tissues with heavy energy demands - muscle, heart and liver - and their target genes encode proteins involved in fatty acid oxidation, mitochondrial biogenesis and the Krebs cycle.
By activating ERR signalling, the compound pushes cells toward burning fat and building mitochondrial capacity - the same adaptation that aerobic training produces. That is the physiological logic behind the expression exercise mimetic, and it is why the research is aimed at obesity and metabolic syndrome rather than at muscle growth.
In the published work, SLU-PP-332 administration mimicked exercise-induced benefits on whole-body metabolism in mice: increased energy expenditure and fatty acid oxidation, accompanied by decreased fat mass accumulation. In models of metabolic syndrome it reduced obesity and improved insulin sensitivity. The dosing used was 50 mg per kilogram intraperitoneally twice daily for 28 days, with measurable plasma and muscle exposure at a lower 30 mg/kg dose.
There is no human dose, and the mouse protocol used injectable milligram-per-kilogram amounts - which is fundamentally different from taking a fixed microgram tablet once a day. The 1000 mcg tablet here reflects research product convention rather than a validated schedule, so any oral dosing pattern is extrapolation.
There is no human pharmacokinetics, no human safety data and no established half-life, which is why this card lists it as not established rather than quoting a figure from a forum. SLU-PP-332 remains a laboratory compound with an interesting mechanism and a single published body of animal evidence.
Because the compound has never been given to humans in a published trial, there is no side effect profile to report - only the theoretical considerations of activating a nuclear receptor family involved in mitochondrial and lipid metabolism. That is a genuine unknown rather than a reassurance. Anyone comparing it with metabolic compounds that do have human data, such as GW 501516 - which was abandoned after animal cancer findings - should weigh the absence of data accordingly.
It belongs with the metabolic research group rather than the androgens. GW 501516 is the other PPAR-based exercise mimetic in this catalog, and it carries a cancer signal from animal testing that SLU-PP-332 simply has not been tested long enough to match or clear. MK 677 raises growth hormone through the ghrelin receptor, appetite-focused peptides such as Sema-Pep and Retatrutide work on gut-hormone receptors, and the classic SARMs (Ostarine, LGD 4033) act on the androgen receptor. None of them share SLU-PP-332's mechanism.
Store the tablets at room temperature in a dry place, away from direct light and moisture. Keep the pack sealed until use and always store it out of the reach of children.
At XSteroids you buy the Dragon Pharma SLU-PP-332 tablets directly from the brand catalog, with secure checkout, US domestic shipping in 3 to 6 days and international delivery in 12 to 26 days. Browse the full range on the Dragon Pharma brand page to complete your research protocol.
SLU-PP-332 is an agonist of the estrogen-related receptors - ERR-alpha, ERR-beta and ERR-gamma. It is a research compound studied as an exercise mimetic. Dragon Pharma supplies it as 1000 mcg tablets, 100 per pack. It has no human trial data.
ERRs are constitutively active orphan nuclear receptors concentrated in muscle, heart and liver. Their target genes drive fatty acid oxidation, mitochondrial biogenesis and the Krebs cycle, so activating them pushes tissue toward burning fat and building mitochondrial capacity in those tissues.
There is no human dose. The published mouse work used 50 mg per kilogram intraperitoneally twice daily for 28 days, which is a different route and scale from an oral microgram tablet. Any oral schedule is extrapolation from animal work rather than evidence.
Neither. It acts on the estrogen-related receptors, a nuclear receptor family involved in energy metabolism, rather than the androgen receptor. It is sold in the SARM category, which is a merchandising decision rather than a pharmacological one in any real sense.
There is no published human safety data, so there is no side effect profile to report. The theoretical considerations relate to activating a receptor family that governs mitochondrial and lipid metabolism, which is an unknown rather than a reassurance for users.
No. The evidence is from mouse studies, including models of obesity and metabolic syndrome, where it increased energy expenditure and fatty acid oxidation and reduced fat mass. No human trial data exists for this compound at all, so the animal findings stay provisional.
You can buy SLU-PP-332 1000 mcg tablets by Dragon Pharma online at XSteroids. The store offers secure checkout, US domestic shipping in 3 to 6 days and international delivery in 12 to 26 days. Add the pack to your cart on this page. All orders ship with tracking.
Loading...
Your cart is currently empty. Let us assist you in finding the right product